Composition and Biological Activity of Flavonoid-containing Fractions of an Extract from Gratiola officinalis L.

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL Anti-cancer agents in medicinal chemistry Pub Date : 2024-11-05 DOI:10.2174/0118715206323280241029215900
Alexander Shirokov, Vyacheslav Grinev, Matvey Kanevskiy, Yulia Fedonenko, Larisa Matora, Natalya Polukonova, Dmitry Mudrak, Artyom Mylnikov, Anna Polukonova, Alla Bucharskaya, Nikita Navolokin, Galina Maslyakova
{"title":"Composition and Biological Activity of Flavonoid-containing Fractions of an Extract from Gratiola officinalis L.","authors":"Alexander Shirokov, Vyacheslav Grinev, Matvey Kanevskiy, Yulia Fedonenko, Larisa Matora, Natalya Polukonova, Dmitry Mudrak, Artyom Mylnikov, Anna Polukonova, Alla Bucharskaya, Nikita Navolokin, Galina Maslyakova","doi":"10.2174/0118715206323280241029215900","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Gratiola officinalis L. (hedge hyssop), a medicinal plant of the Scrophulariaceae family, has diuretic, purgative, and vermifuge properties. It is used as a herbal tea to treat chronic gastroenteritis, renal colic, jaundice, and intestinal worms. Previously, we have found that an extract from G. officinalis is nontoxic and has antitumor, antioxidant, antimicrobial, antiinflammatory, anticachexic, and other properties. Our aims in this study were to separate the G. officinalis extract into individual fractions, to identify the most biologically active fractions, and to examine the chemical composition of these fractions and their biological activity toward A498 renal carcinoma cells.</p><p><strong>Methods: </strong>The G. officinalis extract was fractionated by reversed-phase high-performance liquid chromatography, and each fraction was tested for antitumor activity. The active fractions were characterized by UV-visible electron spectral analysis, circular dichroism analysis, Fourier transform infrared spectroscopy, high-performance liquid chromatography, electrospray ionization tandem mass spectrometry, and nuclear magnetic resonance spectroscopy.</p><p><strong>Results: </strong>Two antitumor-active fractions of a flavonoid nature were isolated and chromatographically purified. On the basis of the nuclear magnetic resonance data, the aglycone fragment of the main component of one fraction was found to be structured as 2-(3,4-dimethoxyphenyl)-7-hydroxychroman-4-one, or 3',4'-dimethoxy-7- hydroxyflavanone.</p><p><strong>Conclusion: </strong>The antitumor effect of the most active fraction containing 7-O-glucoside of apigenin, glycoside 7,3'-di-O-luteolin and trace amounts of eupatilin against renal carcinoma A498 cells was manifested in its cytotoxic, cytostatic, apoptotic and autophagosomal activities. In addition, we found 3-(1-2)-glucoside of soyaspogenol B, which is a pentacyclic triterpenoid in the structure.</p>","PeriodicalId":7934,"journal":{"name":"Anti-cancer agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anti-cancer agents in medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0118715206323280241029215900","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Gratiola officinalis L. (hedge hyssop), a medicinal plant of the Scrophulariaceae family, has diuretic, purgative, and vermifuge properties. It is used as a herbal tea to treat chronic gastroenteritis, renal colic, jaundice, and intestinal worms. Previously, we have found that an extract from G. officinalis is nontoxic and has antitumor, antioxidant, antimicrobial, antiinflammatory, anticachexic, and other properties. Our aims in this study were to separate the G. officinalis extract into individual fractions, to identify the most biologically active fractions, and to examine the chemical composition of these fractions and their biological activity toward A498 renal carcinoma cells.

Methods: The G. officinalis extract was fractionated by reversed-phase high-performance liquid chromatography, and each fraction was tested for antitumor activity. The active fractions were characterized by UV-visible electron spectral analysis, circular dichroism analysis, Fourier transform infrared spectroscopy, high-performance liquid chromatography, electrospray ionization tandem mass spectrometry, and nuclear magnetic resonance spectroscopy.

Results: Two antitumor-active fractions of a flavonoid nature were isolated and chromatographically purified. On the basis of the nuclear magnetic resonance data, the aglycone fragment of the main component of one fraction was found to be structured as 2-(3,4-dimethoxyphenyl)-7-hydroxychroman-4-one, or 3',4'-dimethoxy-7- hydroxyflavanone.

Conclusion: The antitumor effect of the most active fraction containing 7-O-glucoside of apigenin, glycoside 7,3'-di-O-luteolin and trace amounts of eupatilin against renal carcinoma A498 cells was manifested in its cytotoxic, cytostatic, apoptotic and autophagosomal activities. In addition, we found 3-(1-2)-glucoside of soyaspogenol B, which is a pentacyclic triterpenoid in the structure.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
草决明提取物中含类黄酮馏分的成分和生物活性
简介Gratiola officinalis L.(篱笆牛膝草)是一种 Scrophulariaceae 家族的药用植物,具有利尿、清热和驱虫的功效。它被用作草药茶来治疗慢性肠胃炎、肾绞痛、黄疸和肠虫病。此前,我们发现 G. officinalis 的提取物无毒,并具有抗肿瘤、抗氧化、抗菌、抗炎、抗心绞痛等特性。本研究的目的是将 G. officinalis 提取物分离成单个馏分,确定最具生物活性的馏分,并研究这些馏分的化学成分及其对 A498 肾癌细胞的生物活性:方法:采用反相高效液相色谱法对麝香草提取物进行分馏,并对每个馏分进行抗肿瘤活性测试。通过紫外可见电子能谱分析、圆二色光谱分析、傅立叶变换红外光谱、高效液相色谱法、电喷雾离子化串联质谱法和核磁共振波谱法对活性馏分进行表征:结果:分离并色谱纯化了两种具有抗肿瘤活性的黄酮类成分。根据核磁共振数据,发现其中一个馏分主要成分的苷元片段结构为 2-(3,4-二甲氧基苯基)-7-羟基色满-4-酮或 3',4'-二甲氧基-7-羟基黄烷酮:含有芹菜苷的 7-O 葡萄糖苷、7,3'-二-O-木犀草苷和微量 eupatilin 的最有效组分对肾癌 A498 细胞的抗肿瘤作用体现在细胞毒性、细胞抑制、细胞凋亡和自噬体活性上。此外,我们还发现了大豆天冬皂苷 B 的 3-(1-2)-葡萄糖苷,其结构属于五环三萜类化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Anti-cancer agents in medicinal chemistry
Anti-cancer agents in medicinal chemistry ONCOLOGY-CHEMISTRY, MEDICINAL
CiteScore
5.10
自引率
3.60%
发文量
323
审稿时长
4-8 weeks
期刊介绍: Formerly: Current Medicinal Chemistry - Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
期刊最新文献
Amide Functionalized Novel Pyrrolo-pyrimidine Derivative as Anticancer Agents: Synthesis, Characterization and Molecular Docking Studies. Composition and Biological Activity of Flavonoid-containing Fractions of an Extract from Gratiola officinalis L. Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors. A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy? In vivo, In vitro, and In silico Studies of Umbelliferone and Irinotecan on MDA-MB-231 Breast Cancer Cell Line and Drosophila melanogaster Larvae.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1